Intrauterine infusion of human chorionic gonadotropin, peripheral blood mononuclear cells, granulocyte-colony-stimulating factor, and platelet-rich plasma seems a promising strategy for improving the pregnant outcomes for infertile patients with recurrent implantation failure. The gene discussed is CSF3; the disease is Infertility.